A BNY MELLON COMPANY

Dreyfus Research Long/Short Equity Fund

  • Ticker: DLSAX
  • Product Code: 6116
  • CUSIP: 26202X694
Share Class:

Portfolio Manager/Sub-Investment Adviser

The fund's investment adviser is The Dreyfus Corporation (Dreyfus). Dreyfus has engaged its affiliate, The Boston Company Asset Management, LLC (TBCAM), to serve as the fund's sub-investment adviser. Investment decisions for the fund are made by members of TBCAM's global research team. The team members primarily responsible for managing the fund are Elizabeth Slover, Matthew D. Griffin, CFA, and Matthew T. Jenkin. This position has been held by Ms. Slover and Mr. Griffin since the fund's inception in July 2013 and by Mr. Jenkin since December 2015. Ms. Slover is a senior managing director at TBCAM, and is the director of TBCAM's global research team. Mr. Griffin is a managing director and portfolio manager at TBCAM, and is a member of TBCAM's global research team. Mr. Jenkin is a senior research analyst on TBCAM's global research team.

Top Holdings 2

Conagra Foods 2.39%
Molson Coors Brewing, Cl. B 2.01%
Boston Scientific 1.94%
Petroleo Brasileiro, ADR 1.70%
Broadcom 1.62%
Alphabet, Cl. C 1.59%
Costco Wholesale 1.57%
Visa, Cl. A 1.55%
Merck & Co. 1.50%
The TJX Companies 1.50%

Portfolio Statistics

Number of Holdings 68
as of 10/31/16
Portfolio Turnover Rate 359.78%
as of fiscal year end 10/31/15
P/E Ratio 3 20.37
as of 10/30/16

Risk Measures

as of 11/30/16
R Squared 4 34.01
Beta 5 0.25
Standard Deviation 6 4.70

Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. Download a prospectus, or a summary prospectus, if available, that contains this and other information about the fund, and read it carefully before investing.

Notes & Disclosures
  1. Portfolio composition and allocation is as of 10/31/16 and is subject to change at any time. Totals may not be exact due to rounding. Negative exposures may represent short positions through derivatives.
  2. The holdings listed should not be considered recommendations to buy or sell a security. Large concentrations can increase share price volatility.
  3. Price/earnings for a stock is the ratio of the company's most recent month-end share price to the company's estimated earnings per share (EPS) for the current fiscal year. If a third-party estimate for the current year EPS is not available, Morningstar will calculate an internal estimate based on the most recently reported EPS and average historical earnings growth rates. Price/ earnings is one of the five value factors used to calculate the Morningstar Style Box. For portfolios, this historical P/E data point is calculated by taking an asset-weighted average of the earnings yields (E/P) of all the stocks in the portfolio and then taking the reciprocal of the result. Source: Morningstar
  4. Reflects the percentage of a fund's movements that can be explained by movements in a particular benchmark. An R-squared of 100 indicates fund movements that are perfectly correlated to those of the benchmark. In order to compare funds across general asset classes, Morningstar calculates R-squared values relative to a "standard" broad-based market index. For example, the R-squared of both a small cap, domestic equity fund and a domestic technology fund would be determined against the S&P 500 Index. Thus, the "standard" broad-based market index used by Morningstar may differ from the fund's actual benchmark stated in this factsheet. Source: Morningstar
  5. Beta is a measure of the systematic risk of a stock or a portfolio and is an indicator of expected return. A beta higher than 1.0 has higher risk than the overall market has and thus the stock or portfolio can be expected to perform in relation to the overall market in that way.
  6. A statistical measurement of dispersion around an average which depicts how widely fund returns varied over a certain period of time. Source: Morningstar
Choose a date range

Quick Links